The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Objectives: This meta-analysis of randomized controlled trials (RCTs) investigated the usefulness of mesenchymal stromal cells (MSCs) to treat patients with COVID-19. Methods: PubMed, Embase, Ovid MEDLINE, the Cochrane Library, and Clinicaltrials.gov were searched for RCTs published before November...
Main Authors: | Ching-Yi Chen, Wang-Chun Chen, Chi-Kuei Hsu, Chien-Ming Chao, Chih-Cheng Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034122001794 |
Similar Items
-
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
by: Maurice A. Canham, et al.
Published: (2020-09-01) -
Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy
by: Eleonora Russo, et al.
Published: (2023-06-01) -
Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
by: Kátia Nunes da Silva, et al.
Published: (2021-07-01) -
Preconditioned Mesenchymal Stromal Cells to Improve Allotransplantation Outcome
by: Hui-Yun Cheng, et al.
Published: (2021-09-01) -
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
by: Fermín Sánchez-Guijo, et al.
Published: (2020-08-01)